scholarly article | Q13442814 |
meta-analysis | Q815382 |
P356 | DOI | 10.3233/JAD-148009 |
P8608 | Fatcat ID | release_rlcnnab4dbeupmtysjnvmek4ji |
P932 | PMC publication ID | 4398648 |
P698 | PubMed publication ID | 25690665 |
P50 | author | Alexander Niculescu | Q4719749 |
Alzheimer's Disease Neuroimaging Initiative | Q4738819 | ||
Tatiana Foroud | Q28516692 | ||
Andrew J. Saykin | Q30514182 | ||
Shannon L. Risacher | Q87217788 | ||
Kwangsik Nho | Q87614152 | ||
Sungeun Kim | Q61072086 | ||
Martin R. Farlow | Q67212573 | ||
Brenna C. McDonald | Q87217754 | ||
P2093 | author name string | Vijay K Ramanan | |
Christopher M Callahan | |||
Hugh C Hendrie | |||
Emrin Horgusluoglu | |||
Mark H Inlow | |||
P2860 | cites work | A Swedish National Twin Study of Lifetime Major Depression | Q22306276 |
Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease | Q24644398 | ||
Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics | Q24685475 | ||
Principal components analysis corrects for stratification in genome-wide association studies | Q27860975 | ||
The glutamate receptor ion channels | Q28137916 | ||
Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7 | Q28507609 | ||
Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7 | Q28585707 | ||
A genome-wide association study of depressive symptoms | Q28943434 | ||
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes | Q29417138 | ||
Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort | Q29417147 | ||
Identification of positive allosteric modulators VU0155094 (ML397) and VU0422288 (ML396) reveals new insights into the biology of metabotropic glutamate receptor 7 | Q30402875 | ||
The genetics of major depression: moving beyond the monoamine hypothesis | Q33669125 | ||
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans | Q33846034 | ||
Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds. | Q33874459 | ||
Molecular frequency filters at central synapses | Q33927927 | ||
Gene-based tests of association | Q33987507 | ||
Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned | Q34147518 | ||
Pathway analysis of genomic data: concepts, methods, and prospects for future development | Q34223263 | ||
Targeting of NMDA receptors in the treatment of major depression | Q34397015 | ||
Depression in the elderly | Q34423873 | ||
Allelic association, DNA resequencing and copy number variation at the metabotropic glutamate receptor GRM7 gene locus in bipolar disorder | Q34507224 | ||
Activation of the mGlu7 receptor elicits antidepressant-like effects in mice | Q34648343 | ||
Meta-analyses of genetic studies on major depressive disorder | Q34701323 | ||
Depression and anxiety symptoms in male veterans and non-veterans: the Health and Retirement Study | Q35108966 | ||
A conserved BDNF, glutamate- and GABA-enriched gene module related to human depression identified by coexpression meta-analysis and DNA variant genome-wide association studies | Q35114644 | ||
Neuropsychiatric symptoms in Alzheimer's disease | Q35823575 | ||
Plasma biomarkers of depressive symptoms in older adults | Q35844316 | ||
The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: a meta-analysis | Q36110161 | ||
A 3p26-3p25 genetic linkage finding for DSM-IV major depression in heavy smoking families | Q36206875 | ||
HYST: a hybrid set-based test for genome-wide association studies, with application to protein-protein interaction-based association analysis | Q36439328 | ||
Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis | Q36465225 | ||
Genome-wide pathway analysis of memory impairment in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks | Q37019930 | ||
Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers | Q37159843 | ||
Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment | Q37183109 | ||
Genome-wide association analysis of copy number variation in recurrent depressive disorder. | Q37611740 | ||
Depression and Alzheimer's disease: is stress the initiating factor in a common neuropathological cascade? | Q37811712 | ||
A new lead from genetic studies in depressed siblings: assessing studies of chromosome 3. | Q37911082 | ||
A breach in the scaffold: the possible role of cytoskeleton dysfunction in the pathogenesis of major depression | Q38045080 | ||
Role of lithium augmentation in the management of major depressive disorder | Q38192967 | ||
The importance of cytokines and autoantibodies in depression | Q38252994 | ||
Severe Progressive Autism Associated with Two de novo Changes: A 2.6-Mb 2q31.1 Deletion and a Balanced t(14;21)(q21.1;p11.2) Translocation with Long-Range Epigenetic Silencing of LRFN5 Expression | Q40989548 | ||
Acute antidepressant treatment differently modulates ERK/MAPK activation in neurons and astrocytes of the adult mouse prefrontal cortex. | Q42517899 | ||
Contribution of genetic and environmental influences to ankle-brachial blood pressure index in the NHLBI Twin Study. National Heart, Lung, and Blood Institute | Q42620853 | ||
Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects | Q43594315 | ||
Cytokine-associated emotional and cognitive disturbances in humans | Q43601371 | ||
A genome-wide significant linkage for severe depression on chromosome 3: the depression network study | Q43756830 | ||
Genetic susceptibility to accelerated cognitive decline in the US Health and Retirement Study | Q45826128 | ||
Total ERK1/2 activity regulates cell proliferation | Q46109721 | ||
Longitudinal changes in the contribution of genetic and environmental influences to symptoms of depression in older male twins | Q46211862 | ||
Reversal of hypogonadotropic hypogonadism with tamoxifen in a patient with hyperprolactinemia resistant to dopamine agonists | Q46708934 | ||
Maintenance treatment with fluoxetine is necessary to sustain normal levels of synaptic markers in an experimental model of depression: correlation with behavioral response | Q46936548 | ||
Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: a light and electron microscopic study | Q48487757 | ||
Gender differences in heritability of depressive symptoms in the elderly. | Q51993964 | ||
Altered short-term synaptic plasticity in mice lacking the metabotropic glutamate receptor mGlu7. | Q52007247 | ||
Linkage to 20p13 including the ANGPT4 gene in families with mixed Alzheimer's disease and vascular dementia. | Q53413550 | ||
Variants in Apaf-1 segregating with major depression promote apoptosome function. | Q53611851 | ||
Minority perspectives from the Health and Retirement Study. Introduction: health and retirement among ethnic and racial minority groups. | Q53622888 | ||
Tacrolimus is highly effective in both dual and triple therapy regimens following renal transplantation. Spanish and Italian Tacrolimus Study Group. | Q54027114 | ||
Role of shared genetic and environmental factors in symptoms of depression and body composition | Q57309112 | ||
LYMPHOKINE RELEASE FROM HUMAN LYMPHOMONONUCLEAR CELLS AFTER CO-CULTURE WITH ISOLATED PANCREATIC ISLETS: EFFECTS OF ISLET SPECIES, LONG-TERM CULTURE, AND MONOCYTE-MACROPHAGE CELL REMOVAL | Q57504397 | ||
Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression | Q80996268 | ||
P433 | issue | 4 | |
P304 | page(s) | 1197-1206 | |
P577 | publication date | 2015-01-01 | |
P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
P1476 | title | Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults | |
P478 | volume | 45 |
Q97643162 | A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer's disease |
Q91620808 | Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs |
Q48066803 | Depression as a risk factor for Alzheimer's disease: Genes, steroids, cytokines and neurogenesis - What do we need to know? |
Q98384889 | Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics |
Q39301735 | From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms |
Q64963702 | GRIK4 and GRM7 gene may be potential indicator of venlafaxine treatment reponses in Chinese of Han ethnicity. |
Q26801647 | Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans |
Q40353484 | Genome-wide Regional Heritability Mapping Identifies a Locus Within the TOX2 Gene Associated With Major Depressive Disorder |
Q38376090 | Genome-wide association study of language performance in Alzheimer's disease |
Q26778022 | Mitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancer |
Q42696742 | Mood, stress and longevity: convergence on ANK3. |
Q90295915 | Morphological changes in subregions of hippocampus and amygdala in major depressive disorder patients |
Q37183072 | Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors |
Q52576146 | SALM/Lrfn Family Synaptic Adhesion Molecules. |
Q38658765 | Stress, depression, resilience and ageing: A role for the LPA-LPA1 pathway. |
Q38768169 | The psychosis spectrum in Parkinson disease |
Search more.